SUBSCRIBE
SUBSCRIBE
News   Drug Development

Covance Inc. Increases Its Phase I Clinical Capacity With Acquisition Of Gfi Research Center

October 26, 2005 | 
1 min read
Covance Inc. (NYSE: CVD) added to its Phase I capacity and further enhanced its reputation for clinical excellence with the purchase today of GFI Clinical Services from West Pharmaceutical Services, Inc. (NYSE: WST).
Clinical research Phase I Mergers & acquisitions
MORE ON THIS TOPIC
IN PARTNERSHIP WITH DIA
Eroding Immunity: Vaccine Hesitancy and Cynicism With Paul Offit
May 8, 2025
 · 
1 min read
 · 
Lori Ellis
Computational Biology - The Study of Biological Systems Through Computational Techniques and Modeling - Conceptual Illustration
Gene therapy
CRISPR’s Casgevy on the Rise With More Gene Therapy Proof of Concept To Come in 2025
May 7, 2025
 · 
4 min read
 · 
Annalee Armstrong
Brain with pills, Alzheimer awareness day, dementia diagnosis, Parkinson disease, memory loss disorder, damaged mind
Huntington’s disease
PTC Nosedives Despite Claiming Phase II Win for Huntington’s Hopeful
May 5, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
 · 
2 min read
 · 
Annalee Armstrong